Outcomes in Patients with Intact and Resected Brain Metastasis Treated with 5-Fraction Stereotactic Radiosurgery.
Outcomes in Patients with Intact and Resected Brain Metastasis Treated with 5-Fraction Stereotactic Radiosurgery.
复制标题
采用 5 分次立体定向放射外科治疗的完整脑转移瘤和已切除脑转移瘤患者的结果。
DOI:
10.1016/j.adro.2022.101166
复制
发表时间:
2023-03
影响因子:
2.3
通讯作者:
中科院分区:
文献类型:
--
作者:
Hypofractionated stereotactic radiosurgery (HF-SRS) with or without surgical resection is potentially a preferred treatment for larger or symptomatic brain metastases (BMs). Herein, we report clinical outcomes and predictive factors following HF-SRS. Patients undergoing HF-SRS for intact (iHF-SRS) or resected (rHF-SRS) BMs from 2008 to 2018 were retrospectively identified. Linear accelerator-based image-guided HF-SRS consisted of 5 fractions at 5, 5.5, or 6 Gy per fraction. Time to local progression (LP), time to distant brain progression (DBP), and overall survival (OS) were calculated. Cox models assessed effect of clinical factors on OS. Fine and Gray's cumulative incidence model for competing events examined effect of factors on LP and DBP. The occurrence of leptomeningeal disease (LMD) was determined. Logistic regression examined predictors of LMD. Among 445 patients, median age was 63.5 years; 87% had Karnofsky performance status ≥70. Fifty-three % of patients underwent surgical resection, and 75% received 5 Gy per fraction. Patients with resected BMs had higher Karnofsky performance status (90-100, 41 vs 30%), less extracranial disease (absent, 25 vs 13%), and fewer BMs (multiple, 32 vs 67%). Median diameter of the dominant BM was 3.0 cm (interquartile range, 1.8-3.6 cm) for intact BMs and 4.6 cm (interquartile range, 3.9-5.5 cm) for resected BMs. Median OS was 5.1 months (95% confidence interval [CI], 4.3-6.0) following iHF-SRS and 12.8 months (95% CI, 10.8-16.2) following rHF-SRS (P < .01). Cumulative LP incidence was 14.5% at 18 months (95% CI, 11.4-18.0%), significantly associated with greater total GTV (hazard ratio, 1.12; 95% CI, 1.05-1.20) following iFR-SRS, and with recurrent versus newly diagnosed BMs across all patients (hazard ratio, 2.28; 95% CI, 1.01-5.15). Cumulative DBP incidence was significantly greater following rHF-SRS than iHF-SRS (P = .01), with respective 24-month rates of 50.0 (95% CI, 43.3-56.3) and 35.7% (95% CI, 29.2-42.2). LMD (57 events total; 33% nodular, 67% diffuse) was observed in 17.1% of rHF-SRS and 8.1% of iHF-SRS cases (odds ratio, 2.46; 95% CI, 1.34-4.53). Any radionecrosis and grade 2+ radionecrosis events were observed in 14 and 8% of cases, respectively. HF-SRS demonstrated favorable rates of LC and radionecrosis in postoperative and intact settings. Corresponding LMD and RN rates were comparable to those of other studies.
登录
查看更多内容
DOI:
10.1186/1748-717x-6-48
发表时间:
2011-05-15
期刊:
Radiation oncology (London, England)
影响因子:
--
作者:
Minniti G;Clarke E;Lanzetta G;Osti MF;Trasimeni G;Bozzao A;Romano A;Enrici RM
通讯作者:
Enrici RM
DOI:
10.1016/j.ijrobp.2020.10.034
发表时间:
2021-04-14
影响因子:
7
作者:
Redmond, Kristin J.;Gui, Chengcheng;Kleinberg, Lawrence R.
通讯作者:
Kleinberg, Lawrence R.
DOI:
10.1016/j.ijrobp.2014.09.004
发表时间:
2015-01-01
影响因子:
7
作者:
Kirkpatrick, John P.;Wang, Zhiheng;Yin, Fang-Fang
通讯作者:
Yin, Fang-Fang
DOI:
10.1016/j.ijrobp.2010.05.033
发表时间:
2011-10-01
影响因子:
7
作者:
Kim, Yeon-Joo;Cho, Kwan Ho;Lee, Seung Hoon
通讯作者:
Lee, Seung Hoon
影响因子:
1.3
作者:
Feuvret, L.;Vinchon, S.;Mazeron, J-J
通讯作者:
Mazeron, J-J